Screener
Merck & Co. MRK EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Merck & Co.’s reported figures.
The source filing: Merck & Co.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:10 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0001628280-26-029802
FAQ
- What is Merck & Co.'s EBITDA?
- Merck & Co. (MRK) reported EBITDA of -$2.95B in Q1 2026.
- How has Merck & Co.'s EBITDA changed year-over-year?
- Merck & Co.'s EBITDA decreased by 146.1% year-over-year, from $6.41B to -$2.95B.
- What is the long-term trend for Merck & Co.'s EBITDA?
- Over 3 years (2021 to 2025), Merck & Co.'s EBITDA has grown at a 16.0% compound annual growth rate (CAGR), from $15.46B to $24.11B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Merck & Co.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude